ArticleJournal of gastroenterology2016
Reply to the letter by Takeshi Yamada et al. concerning "Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?".
Jun Zhou et al.PubMed ↗Publisher ↗
No numbers read from the abstract.